Wegovy Pill Just Changed: Why Lilly Stock Could Still Win
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Understanding when to shift from stocks to bonds can enhance your investment strategy. Make informed decisions to maximize returns.
22,202 articlesA new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
A rare public reversal from Elon Musk shines a light on Anthropic as a leading AI player. For Amazon and Alphabet inv...
Policy makers unveiled tax measures aimed at tech profits, rattling a rally that earned the nickname the hottest stoc...
When a mid-cap medical device stock vaults over 5 percent in a single session, investors sit up and take notice. This...
When a fund trims its Planet Fitness position, it sends a message about risk, growth, and the path for 2026. This dee...
Two very different paths define the nuclear renaissance: NuScale's small modular reactors and BWX Technologies' broad...
A Wall Street analyst has highlighted Alphabet's growing AI capabilities, suggesting a shift in the AI compute landsc...
Oklo faces a pivotal moment after July. This piece explains a single catalyst investors should watch, the potential s...
A massive AI-driven data center build-out is changing how investors think about tech stocks. This piece explains the ...
A provocative forecast from Elon Musk about AI-driven code creation is sending ripples through tech equities and hiri...
Nuscale Power stock rocketing headlines point to optimism around small modular reactors, policy momentum, and utility...
AI demand has sparked a rapid rally in memory stocks, but signs of inventory normalization and pricing pressure pose ...